2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-

CAS : 202409-33-4

Ref. AN-AG002878

Informations sur le produit

• Nom: 2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-
• Synonymes: [u'Arcoxia', u'etoricoxib', u'L 791456', u'L-791456', u'L791456', u'MK 0663', u'MK-0663', u'MK0663', u'Etoricoxib', u'202409-33-4', u'Arcoxia', u'Algix', u'Tauxib', u'Nucoxia', u'MK-0663', u'MK-663', u"5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine", u'MK 0663', u'Etoricoxib [USAN:INN:BAN]', u'UNII-WRX4NFY03R', u'L-791456', u'MK 663', u"5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine", u'MK0663', u'WRX4NFY03R', u'L791456', u'5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine', u'CHEBI:6339', u'CHEMBL416146', u'MNJVRJDLRVPLFE-UHFFFAOYSA-N', u"5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine", u'NCGC00164578-01', u'Etoricoxibe', u'AK115816', u'Etropain', u'Torcoxia', u'Etoxib', u'DSSTox_CID_26457', u'DSSTox_RID_81631', u'DSSTox_GSID_46457', u'Kingcox', u"5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl", u'5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine', u'CAS-202409-33-4', u'SR-05000001486', u'Etoricoxib (USAN/INN)', u'etoricoxibum', u'AC1L3WZM', u'SCHEMBL4680', u'GTPL2896', u'DTXSID3046457', u'CTK8E8328', u'HMS2090A05', u'HMS3713P20', u'ZINC579472', u'BCP06428', u'EX-A2642', u'KS-00000G8U', u'Tox21 112206', u'Tox21_112206', u'BDBM50072064', u'Etoricoxib; MK-663; MK-0663', u'MFCD06797512', u's4651', u'AKOS016010125', u'Tox21_112206_1', u'API0002661', u'CCG-220639', u'CS-1047', u'DB01628', u'RTC-030142', u'SB18988', u'NCGC00164578-02', u'5CH', u'AC-29052', u'AJ-23602', u'AN-16569', u'AS-17761', u'CC-28334', u'HY-15321', u'ZB014476', u'AB0020709', u'AX8129880', u'LS-181802', u'TC-030142', u'FT-0082494', u'FT-0602793', u'ST24044654', u'V1697', u'C11718', u'D03710', u'Etoricoxib, VETRANAL(TM), analytical standard', u'W-5339', u'AB01275483-01', u'409E334', u'C-20862', u'L001141', u'J-013140', u'SR-05000001486-1', u'SR-05000001486-2', u'BRD-K54770957-001-01-9', u'BRD-K54770957-001-02-7', u'F2173-0490', u'Etoricoxib, United States Pharmacopeia (USP) Reference Standard', u'5-chloro-2-(6-methyl-3-pyridyl)-3-(4-methylsulfonylphenyl)pyridine', u"5-Chloro-6'-methyl-3-(4-(methylsulfonyl)-phenyl)-2,3'-bipyridine", u"5-Chloro-3-(4-methanesulfonyl-phenyl)-6''''-methyl-[2,3'''']bipyridinyl", u"5-Chloro-3-(4-methanesulfonyl-phenyl)-6''-methyl-[2,3'']bipyridinyl", u'5-chloro-3-(4-methanesulfonylphenyl)-2-(6-methylpyridin-3-yl)pyridine', u'5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-(2-methyl-5-pyridinyl)pyridine', u"5-chloro-6''-methyl-3-[4-(methylsulfonyl)phenyl]-2,3''-bipyridine", u'etobrix', u'etocox', u'Etoricoxib-d3', u'Arcoxia (TN)', u'Etoricoxib [USAN]', u'Tauxib (TN)', u'Algix (TN)', u'D09MGR', u'C18H15ClN2O2S', u'Etoricoxib, 98% - 1G 1g', u'C18-H15-Cl-N2-O2-S', u'CID123619', u'ACN-037621', u'CS-O-10073', u'Merck Sharp & Dohme brand of etoricoxib', u'A3405', u'A13770', u'C422649', u'L 791456', u'D000077613', u"2,3'-bipiridina, 5-cloro-6'-metil-3-[4-(metilsulfonil)fenil]-", u"5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2 3'-bipyridine", u'5-chloro-3-(4-methylsulfonyl)phenyl-2-(2-methyl-5-pyridinyl)pyridine', u"2,?3'-?Bipyridine, 5-?chloro-?6'-?methyl-?3-?[4-?(methylsulfonyl)?phenyl]?-", u'850896-71-8'], 2,3′-Bipyridine, 5-chloro-6′-methyl-3-[4-(methylsulfonyl)phenyl]-, 5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine, 5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)Phenyl]-2,3'-Bipyridine, Algix, Arcoxia, Etobrix, Etocox, Etosaid, Etoxib, Etropain, Kingcox, Mk 0663, Mk 663, Nucoxia, Tauxib, Torcoxia
• CAS: 202409-33-4
• Marque: Indagoo

Propriétés chimiques

• Masse moléculaire: 358.8419
• Formule: C₁₈H₁₅ClN₂O₂S
• Degré de pureté: 98%
• Couleur/Forme: Solid
• InChI: InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3
• Code InChI: MNJVRJDLRVPLFE-UHFFFAOYSA-N